Adenoviral clostridial light chain gene-based synaptic inhibition through neuronal synaptobrevin elimination

Q Teng1, D Tanase, D K Tanase

  • 1Department of Neuroscience, Lerner Research Institute, Cleveland, OH, USA.

Gene Therapy
|October 22, 2004
PubMed

Insights

Researchers developed a method to inhibit nerve cell communication using tetanus toxin light chain (LC) gene delivery. This approach offers a non-damaging way to study neural circuits and potentially treat disorders involving overactive synapses.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Gene Therapy

Background:

  • Clostridial neurotoxins are increasingly used clinically.
  • The light chain (LC) of these toxins inhibits synaptic transmission by cleaving vesicle-docking proteins.
  • Understanding LC gene expression in the nervous system is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the properties of tetanus toxin light chain (LC) gene expression in the nervous system.
  • To assess the functional impact of LC gene delivery on sensorimotor function.
  • To explore the potential of LC gene delivery as a tool for neural inhibition and circuit study.

Main Methods:

  • Construction of an adenoviral vector (AdLC) expressing tetanus toxin LC.
  • In vitro studies using differentiated neuronal PC12 cells to assess synaptobrevin digestion.
  • In vivo studies in rats involving lumbar spinal cord gene transfer and evaluation of sensorimotor function using BBB scale, rotarod, and EMG.

Main Results:

  • AdLC induced time- and concentration-dependent digestion of mouse brain synaptobrevin in vitro.
  • LC gene expression in rat spinal cords impaired hindlimb sensorimotor function (p<0.001 for BBB, p<0.003 for rotarod) and altered EMG responses.
  • No neuronal damage (TUNEL staining, motor neuron density) was observed, and function recovered as LC expression ceased.

Conclusions:

  • Light chain gene delivery offers a non-destructive method for targeted neural inhibition.
  • This approach can be used to study neural circuitry and potentially treat disorders characterized by excessive synaptic activity.
  • Functional recovery correlates with the cessation of LC gene expression, highlighting the reversibility of the inhibition.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...